Skip to main content

Mild Initial Clinical Course Seen for COVID-19 Vaccine-Linked Myocarditis

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 19, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, Sept. 19, 2024 -- COVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common, according to a study published online in the October issue of eClinicalMedicine.

Supriya S. Jain, M.D., from New York Medical College-Maria Fareri Children's Hospital at Westchester Medical Center in Valhalla, and colleagues examined the clinical characteristics, myocardial injury, and longitudinal outcomes of C-VAM. A total of 333 patients aged 30 years or younger with C-VAM were compared to 100 patients with multisystem inflammatory syndrome in children (MIS-C). The presence of myocardial injury as evidenced by late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) imaging was the primary outcome.

Patients with C-VAM were mainly White (67 percent), adolescent (age, 15.7 ±2.8 years) males (91 percent). The researchers found that compared with MIS-C, the initial clinical course of C-VAM was significantly more likely to be mild (80 versus 23 percent) and cardiac dysfunction was less common (17 versus 68 percent). LGE on CMR was significantly more prevalent in C-VAM than MIS-C (82 versus 16 percent). The probability of LGE was significantly higher in male and older patients and when C-VAM occurred after the first or second versus the third mRNA vaccine dose. At a median follow-up of 178 days, midterm clinical outcomes of C-VAM were reassuring. In 60 percent of patients, LGE persisted at follow-up.

"While midterm clinical sequelae are rare and LGE severity decreases over time, the persistence of LGE at follow-up in most patients warrants continued clinical surveillance, additional research, and longer-term studies in this subset of patients," the authors write.

Several authors disclosed ties to relevant organizations.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted September 2024

Further Support and Information on COVID-19

Read this next

Postpandemic Hospital Occupancy Up to 73.5 Percent, Sparking Concern

FRIDAY, Feb. 21, 2025 -- Postpandemic hospital occupancy is higher than prepandemic and is expected to continue increasing without changes in the hospitalization rate or staffed...

Sisters of Those With Adverse Pregnancy Outcome Also Have Increased CVD Risk

FRIDAY, Feb. 21, 2025 -- Women with adverse pregnancy outcomes (APOs) have an increased risk for cardiovascular disease (CVD), as do their APO-free sisters, according to a study...

Chronic Medical Conditions Take Toll on Employees

FRIDAY, Feb. 14, 2025 -- Chronic health conditions are taking a toll on the U.S. workforce's lives and productivity, according to the results of a new Harvard University...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.